Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Inventory (2020 - 2025)

Eton Pharmaceuticals' Change in Inventory history spans 6 years, with the latest figure at -$5.6 million for Q3 2025.

  • For Q3 2025, Change in Inventory fell 4218.46% year-over-year to -$5.6 million; the TTM value through Sep 2025 reached $5.6 million, up 528.86%, while the annual FY2024 figure was $1.3 million, 270.06% up from the prior year.
  • Change in Inventory for Q3 2025 was -$5.6 million at Eton Pharmaceuticals, down from $11.4 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $11.4 million in Q2 2025 and bottomed at -$5.6 million in Q3 2025.
  • The 5-year median for Change in Inventory is $21000.0 (2022), against an average of $428705.9.
  • The largest YoY upside for Change in Inventory was 4650.8% in 2025 against a maximum downside of 4218.46% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $216000.0 in 2021, then crashed by 64.81% to $76000.0 in 2022, then tumbled by 284.21% to -$140000.0 in 2023, then skyrocketed by 302.14% to $283000.0 in 2024, then crashed by 2083.75% to -$5.6 million in 2025.
  • Per Business Quant, the three most recent readings for ETON's Change in Inventory are -$5.6 million (Q3 2025), $11.4 million (Q2 2025), and -$468000.0 (Q1 2025).